☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
generics
PhaseBio Reports First Patients Dosing in its P-III REVERSE-IT Study of Bentracimab in Canada
October 7, 2020
WHO Signs MoU with IGBA for Promoting the Access to Biosimilars and Generics
October 24, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
